(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2,16-bis(1-methylpiperidinium-1-yl)androstane dibromide |
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromide |
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromide |
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromide |
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-2,15-dimethyl-13-(1-methylpiperidin-1-ium-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-4-yl]-1-methylpiperidin-1-ium |
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-BIS(ACETYLOXY)-2,15-DIMETHYL-13-(1-METHYLPIPERIDIN-1-IUM-1-YL)TETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECAN-4-YL]-1-METHYLPIPERIDIN-1-IUM DIBROMIDE |
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-2,15-dimethyl-4-(1-methylpiperidin-1-ium-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-13-yl]-1-methylpiperidin-1-ium |
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-2,15-dimethyl-4-(1-methylpiperidin-1-ium-1-yl)tetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadecan-13-yl]-1-methylpiperidin-1-ium |
1,1'-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3,17-diacetoxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-2,16-diyl)bis(1-methylpiperidin-1-ium) bromide |
1,1'-([2beta,3alpha,5alpha,16beta,17beta]-3,17-Bis[acetyloxy]androstane-2,16-diyl)bis(1-methylpiperidinium) dibromide |
1,1'-(3,17-Bis(acetyloxy)androstane-2,16-diyl)bis(1-methylpiperidinium) dibromide |
1,1'-(3alpha,17beta-Bis(acetyloxy)-5alpha-androstane-2beta,16beta-diyl)bis(1-methylpiperidinium) dibromide |
1,1'-(3alpha,17beta-Dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methylpiperidinium) dibromide diacetate |
1,1'-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(Acetyloxy)androstane-2,16-diyl]bis(1-methylpiperidinium) dibromide |
1,1'-[2 beta,3alpha,5alpha,16 beta,17 beta)-3,17-bis(acetyloxy)-androstane-2,16-diyl]bis[1-methylpiperidinium] dibromide |
15500-66-0 |
16974-53-1 |
2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-diol diacetate dimethobromide |
2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-dioldiacetatedimethobromide |
3-alpha,17-beta-Diacetoxy-2-beta,16-beta-dipiperidino-5-alpha-androstane dimethobromide |
3alpha,17beta-diacetoxy-2beta,16beta-bis(1-methylpiperidinium-1-yl)-5alpha-androstane |
3alpha,17beta-diacetoxy-2beta,16beta-bis(1-methylpiperidinium-1-yl)-5alpha-androstane dibromide |
3alpha,17beta-Diacetoxy-2beta,16beta-dipiperidino-5alpha-androstane dimethobromide |
500P660 |
5alpha-Androstan-3alpha,17beta-diol, 2beta,16beta-dipipecolinio-, dibromide, diacetate |
AB0013311 |
AB00384328 |
AB00384328_11 |
AB00384328-09 |
AB00384328-10 |
AB2000602 |
AC1L1D1A |
AC1L9AWJ |
AC1NTUSZ |
Ambap15500-66-0 |
AN-7536 |
BPBio1_001372 |
Bromure de pancuronium |
Bromure de pancuronium [INN-French] |
bromurex |
Bromuro de pancuronio |
Bromuro de pancuronio [INN-Spanish] |
BSPBio_001247 |
C-54927 |
C07551 |
C35H60Br2N2O4 |
C35H60N2O4 |
CAS-15500-66-0 |
CCG-204969 |
CCG-221034 |
CCG-222191 |
CHEBI:7907 |
CHEBI:7908 |
CHEMBL1200757 |
CHEMBL185073 |
CS-2535 |
D00492 |
D0AA0L |
DB01337 |
DSSTox_CID_3415 |
DSSTox_GSID_23415 |
DSSTox_RID_77018 |
DTXSID7048405 |
DTXSID9023415 |
EBD2199002 |
EINECS 239-532-5 |
EU-0100887 |
GTPL4001 |
H857 |
HMS1571O09 |
HMS2089M07 |
HMS2098O09 |
HMS2231G20 |
HMS3262B16 |
HSDB 3244 |
HY-B0429 |
J76UF062FS |
Lopac0_000887 |
LP00887 |
LS-116480 |
MFCD00079223 |
Mioblock |
MLS000069586 |
MLS001333694 |
MolPort-003-938-961 |
NA 97 |
NCGC00023037-03 |
NCGC00023037-04 |
NCGC00023037-05 |
NCGC00163232-01 |
NCGC00261572-01 |
NSC 293162 |
NSC293162 |
ORG NA 97 |
ORG-NA 97 |
P 1918 |
Pancuronii bromidum |
Pancuronii bromidum [INN-Latin] |
pancuronium |
Pancuronium (dibromide) |
Pancuronium bromide (JP15/USAN/INN) |
Pancuronium bromide (JP17/USAN/INN) |
Pancuronium bromide [USAN:BAN:INN:JAN] |
Pancuronium bromide [USAN:USP:INN:BAN:JAN] |
Pancuronium bromide for system suitability, European Pharmacopoeia (EP) Reference Standard |
Pancuronium bromide, European Pharmacopoeia (EP) Reference Standard |
Pancuronium bromide, United States Pharmacopeia (USP) Reference Standard |
Pancuronium cation |
Pancuronium dibromide |
Pavulon |
Pavulon (TN) |
Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl-, dibromide |
Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl)-, dibromide |
Piperidinium, 1,1'-(2-beta,16-beta-(3-alpha,17-beta-dihydroxy-5-alpha-androstanylene))bis(1-methyl-, dibromide, diacetate |
Piperidinium, 1,1'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methyl-, dibromide, diacetate |
Piperidinium, 1,1'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methyl-, dibromide, diacetate (8CI) |
Piperidinium, 1,1'-[(2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-3,17-bis(acetyloxy)androstane-2,16-diyl]bis[1-methyl-, dibromide |
PL001054 |
Poncuronium bromide |
Prestwick0_001034 |
Prestwick1_001034 |
Prestwick2_001034 |
Prestwick3_001034 |
Q-101015 |
s2497 |
SC-22780 |
SCHEMBL13790650 |
SCHEMBL41185 |
SMR000058820 |
SPBio_003098 |
SR-01000000127 |
SR-01000000127-3 |
Tox21_112033 |
Tox21_500887 |
U9LY9Y75X2 |
UNII-J76UF062FS |
UNII-U9LY9Y75X2 |
ZINC4097383 |